Skip to main content

Care Delivery

Is Value-Based Pricing the Solution to Controlling the Cost of Oncology Drugs?
By Meg Barbor, MPH
Care Delivery
February 2017, Vol 7, No 2
Anticancer drugs should be priced based on the value they deliver to patients, according to Peter B. Bach, MD, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York. Read More ›